SURG vs VZ
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 31, 2026
SURG
VZ
Investment Advisor Scores
VZ
AI Analyst Insights
Detailed Metrics Comparison
| Metric | SURG | VZ | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 3.3546 | 10.01 | SURG |
| PEG Ratio | 0.5333 | 0.9486 | SURG |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 40.7% | -0.7% | SURG |
| Earnings Growth | -77.7% | -22.0% | VZ |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 51.9/100 | 42.6/100 | SURG |
| Profit Margin | -47.9% | 11.6% | VZ |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
SURG
MarkdownPrice below a falling SMA50 (slope -26.6%), weak momentum, RSI 34
VZ
MarkupPrice above SMA50, rising 50-day trend (1.3% over 20 days), RSI 65
Fundamentals Snapshot
| Metric | SURG | VZ |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 3.3 | 9.5 |
| Trailing P/E | — | 12.9 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.4% | 0.0% |
| Gross Margin | -0.2% | 0.6% |
| Operating Margin | 0.2% | 0.2% |
| EPS | -1.49 | 3.89 |
| Dividend Yield | — | 0.06% |